Anti-Inflammatory Drug Offers Hope | Breakthroughs Can't Wait
What if we could reset the balance between inflammation and anti-inflammation in the body?That’s exactly what researchers Paul Shapiro, PhD (University of Maryland School of Pharmacy), and Jeffrey Hasday, MD (University of Maryland School of Medicine), are working toward.By exploring protein kinases—enzymes involved in regulating inflammation—they’re investigating ways to support long-term health and conditions related to immune overreaction, such as respiratory and muscular disorders.#BreakthroughsCantWaitUMB #InflammationResearch #ChronicPain #NIH
More from Youtube
- 0:40Balancing Inflammation: Hope for Reducing ARDS ComplicationsWhat if we could help the body manage inflammation before it becomes dangerous? At the University of Maryland, Baltimore, researchers Paul Shapiro, PhD, and Jeffrey Hasday, MD, are studying protein kinases — enzymes that regulate immune signaling. Their work could lead to breakthroughs in reducing acute respiratory distress syndrome (ARDS) and related health issues.#BreakthroughsCantWaitUMB #ARDS #MedicalResearch #Inflammation #PharmaceuticalScience #ImmuneBalance #BreakthroughsCantWaitUMB
- 0:57Anti-Inflammatory Drug Offers Hope | Breakthroughs Can't WaitWhat if we could reset the balance between inflammation and anti-inflammation in the body?That’s exactly what researchers Paul Shapiro, PhD (University of Maryland School of Pharmacy), and Jeffrey Hasday, MD (University of Maryland School of Medicine), are working toward.By exploring protein kinases—enzymes involved in regulating inflammation—they’re investigating ways to support long-term health and conditions related to immune overreaction, such as respiratory and muscular disorders.#BreakthroughsCantWaitUMB #InflammationResearch #ChronicPain #NIH